Drug
Eleclazine clinical trials
Also written GS-6615.
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2013
How studies write it
Studies that test it under each name
Name
Development codes
- GS-6615
- 10
Studies by the year they started
10 studies that test it; most in 2015 (6)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses eleclazine is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 SyndromeCompletedPhase 1Gilead SciencesNCT02365506Written as Eleclazine
- Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionCompletedPhase 1Gilead SciencesNCT02412098Written as Eleclazine
- Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-DefibrillatorCompletedPhase 2Gilead SciencesNCT02104583Written as Eleclazine
- Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic CardiomyopathyTerminatedPhase 2/3Gilead SciencesNCT02291237Written as Eleclazine
- Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3TerminatedPhase 3Gilead SciencesNCT02300558Written as Eleclazine
- Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal FunctionCompletedPhase 1Gilead SciencesNCT02441829Written as Eleclazine
- GS-6615 in Adults With Chronic Stable Angina and Coronary Artery DiseaseWithdrawnPhase 2Gilead SciencesNCT02377336Written as GS-6615
- Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy AdultsCompletedPhase 1Gilead SciencesNCT02365532Written as GS-6615
- Study of the Effect of GS-6615 in Subjects With LQT-3CompletedPhase 1Gilead SciencesNCT01849003Written as GS-6615
- A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy SubjectsCompletedPhase 1Gilead SciencesNCT01847391Written as GS-6615
Codes
What other systems call eleclazine · ClinicalTrials.gg INT000813
- UNII (FDA) PUY08529FKELECLAZINEConfirmed FDA, Wikidata
- Wikidata Q27077170eleclazineConfirmed FDA, Wikidata
- NCI Thesaurus C174857EleclazineOne source FDA
- DrugBank DB12394One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PUY08529FK | ELECLAZINE | Confirmed FDA, Wikidata |
| Wikidata | Q27077170 | eleclazine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174857 | Eleclazine | One source FDA |
| DrugBank | DB12394 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.